| Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963) |
|---|
| 05/06/2004 | WO2004037814A1 Indazolinone compositions useful as kinase inhibitors |
| 05/06/2004 | WO2004037211A2 Taxane metabolites |
| 05/06/2004 | US20040087547 Orally administered antitumor agents |
| 05/06/2004 | EP1414797A2 Hepatitis c virus polymerase inhibitors with a heterobicylic structure |
| 05/06/2004 | EP1414441A2 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 05/06/2004 | EP1414434A1 Compounds which mimic the chemical and biological properties of discodermolide |
| 05/05/2004 | CN1494545A 非核苷逆转录酶抑制剂 Non-nucleoside reverse transcriptase inhibitors |
| 05/05/2004 | CN1494543A Substituted benzofuran-2-carboxamides derivatives |
| 05/05/2004 | CN1494542A 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin II receptor antagonists |
| 05/05/2004 | CN1494539A Antagonists of MCP-1 function and methods of use thereof |
| 05/05/2004 | CN1148346C Hydrazine derivs. |
| 05/05/2004 | CN1148181C Use of flavnolignanes for the prepn. of medicaments with antiproliferative activity in uterus, ovary and breast |
| 05/04/2004 | US6730799 O-hydroxyethyl-o'-methyl-benzofurandione dioximes are rearranged in the presence of a diluent and in the presence of an acid or a base |
| 05/04/2004 | US6730792 β3 adrenergic agonists |
| 05/04/2004 | US6730782 Carbamoyl substituted β-lactams |
| 04/29/2004 | US20040082780 Vanilloid receptor ligands and their use in treatments |
| 04/29/2004 | US20040082638 Compounds, compositions and methods |
| 04/29/2004 | US20040081664 Oral delivery of a botanical |
| 04/28/2004 | EP1412344A1 Iodobenzopyran-4-one derivatives having fungicidal activity |
| 04/28/2004 | CN1491947A C10 ester carbonate substituted taxadane |
| 04/28/2004 | CN1491946A C 10 ester substituted taxadane |
| 04/27/2004 | US6727251 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 04/22/2004 | WO2004033448A2 Isolation, purification and synthesis of procyanidin b2 and uses thereof |
| 04/22/2004 | WO2004033423A2 Anticancer compounds |
| 04/22/2004 | US20040077670 Novel sulfamides and their use as endothelin receptor antagonists |
| 04/22/2004 | CA2501901A1 Anticancer compounds |
| 04/21/2004 | EP1411052A1 Benzo-fused 5-membered hetrocycle compounds,process for preparation of the same, and use thereof |
| 04/21/2004 | EP1149094B1 4-(aminoalkoxy)benzofurans as n-myristoyltransferase inhibitors |
| 04/21/2004 | EP0904262B1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method |
| 04/21/2004 | CN1491106A Treatment of oesophageal motility disorders and gastro-oesophageal reflux disease |
| 04/20/2004 | US6723730 Capsaicin receptor ligands |
| 04/20/2004 | US6723726 Protein tyrosine kinase inhibitors |
| 04/20/2004 | US6723718 Substituted α, β-anellated butyrolactones |
| 04/15/2004 | WO2004030684A2 Kavalactone product |
| 04/15/2004 | US20040073048 Antitumor agents; anticancer agents; leukemia therapy; using metal alkoxide |
| 04/15/2004 | US20040073047 Preparation of substituted isoserine esters using beta-lactams and metal or ammonium alkoxides |
| 04/15/2004 | US20040072897 Solvent extraction from plant using liquid carbon dioxide; therapy for muscular disorders |
| 04/15/2004 | US20040072889 Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia |
| 04/15/2004 | US20040072870 Anticancer agents |
| 04/15/2004 | US20040072828 2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists |
| 04/15/2004 | US20040071794 Administering methysticin, dihydromethysticin, desmethoxyyangonin, yangonin, dihydrokavain, and/or kavain as drug intensifier |
| 04/14/2004 | EP1406889A2 Interaction inhibitors of tcf-4 with beta-catenin |
| 04/14/2004 | EP1406869A1 Taxol enhancer compounds |
| 04/14/2004 | EP1406696A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease |
| 04/14/2004 | EP1406602A2 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 04/14/2004 | CN1489583A Novel physiologically active substance |
| 04/14/2004 | CN1489582A Dihydronaphthalene devivatives and drugs contanining these compounds as active ingrdeient |
| 04/13/2004 | US6720329 Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE) |
| 04/08/2004 | WO2004028476A2 Artemisinin-derived trioxane dimers |
| 04/08/2004 | WO2004013153A3 Macrolide compounds endowed with antiinflammatory activity |
| 04/08/2004 | WO2003105769A3 Synthetic c-glycolipid and its use for treating cancer infectious diseases and autoimmune diseases |
| 04/08/2004 | US20040068003 Compounds useful for the inhibition of ALDH |
| 04/08/2004 | US20040067946 Phthalatyinone-piperidino-derivatives as pde4 inhibitors |
| 04/08/2004 | US20040067944 Antiarrhythmia agents |
| 04/08/2004 | US20040065866 Low viscosity; solubility at low temperature; low voltage display device |
| 04/07/2004 | EP1149087B1 Piperidine, tetrahydropyridine and piperazine derivatives, their preparation and use |
| 04/07/2004 | CN1487933A Pyrazole compounds useful as protein kinase inhibitors |
| 04/07/2004 | CN1144803C Chinese chestnut flower flavone compound and its extraction process |
| 04/06/2004 | US6716871 Cyclic AMP-specific phosphodie sterase inhibitors |
| 04/06/2004 | US6716850 Non-nucleoside reverse transcriptase inhibitors |
| 04/01/2004 | WO2003099284B1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 04/01/2004 | WO2003059874A3 Aromatic thioether liver x-receptor modulators |
| 04/01/2004 | US20040063973 Process for preparing kifunensine intermediate and kifunensine therefrom |
| 04/01/2004 | US20040063968 Process for use in 11-oxa prostaglandin synthesis |
| 04/01/2004 | US20040063684 Treatment of oesophageal motility disorders and gastro-oesophageal reflux disease |
| 03/31/2004 | EP1401427A2 Non-peptide gnrh agents, pharmaceutical compositions and methods for their uses, and processes for preparing them |
| 03/31/2004 | EP1401392A1 Ascorbyl 2-hexadecanoate as a no-synthase inhibitor |
| 03/31/2004 | EP1019453B1 Aromatic-substituted xanthene dyes |
| 03/31/2004 | EP1010425B1 Remedies for irritable bowel syndrome |
| 03/31/2004 | CN1486312A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1486311A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1486310A Pyrazole compounds useful as protein kinase inhibitors |
| 03/30/2004 | US6713508 Such as 7-(3-(3-trifluoromethyl-7-propyl-6-benz-(4,5)-isoxazoloxy)propoxy)-2 -ethylchromane-2-carboxylic acid which are potent agonists of peroxisome proliferator activated receptor |
| 03/30/2004 | US6713476 Substituted cycloalkyls as inhibitors of a beta protein production |
| 03/25/2004 | WO2004024702A1 Novel carboxamide compounds having an mch-antagonistic effect, medicaments containing said compounds, and methods for the production thereof |
| 03/25/2004 | WO2003040134A9 Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof |
| 03/25/2004 | US20040059138 Dihydropyrancarboxamides and uses thereof |
| 03/25/2004 | US20040058968 Antiinflammatory agents; autoimmune diseases; antiarthritic agents |
| 03/25/2004 | US20040058931 Potassium channel inhibitors and method |
| 03/25/2004 | US20040058853 Multivalent neuraminidase inhibitor conjugates |
| 03/25/2004 | CA2496563A1 New carboxamide compounds having mch-antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture |
| 03/23/2004 | US6710191 9β-hydroxytetracyclic taxanes |
| 03/23/2004 | US6710075 Compounds having a cyclopentabenzofuran core shown to exhibit potent cytotoxic and cytostatic effects on cancer cell growth and viability |
| 03/23/2004 | US6710060 4-hydroxypiperidine derivatives having antiarrhythmic activity |
| 03/18/2004 | WO2004022552A1 Analogs of discodermolide and dictyostatin-1, intermediates therefor and methods of synthesis thereof |
| 03/18/2004 | WO2003095421A8 Amino acid analogues |
| 03/18/2004 | US20040053951 Non-peptide GnRH agents, pharmaceutical compositions, and methods for their use |
| 03/18/2004 | US20040053925 Novel urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use |
| 03/17/2004 | EP1398028A2 Taxanes having alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing same |
| 03/17/2004 | EP1397347A2 Preparation of 17-phenyl- 18, 19, 20- trinor-pgf2a and its derivatives |
| 03/17/2004 | EP1137644B9 Benzofuran derivatives, their preparation and use |
| 03/16/2004 | US6706757 Chroman derivatives as 5-hydroxytryptamine-6 ligands |
| 03/11/2004 | US20040049060 Process for the preparation of paclitaxel |
| 03/11/2004 | US20040049046 Small molecule inhibitors of rotamase enzyme activity |
| 03/11/2004 | US20040048903 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes |
| 03/11/2004 | US20040048894 Compounds which mimic the chemical and biological properties of discodermolide |
| 03/11/2004 | US20040048852 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 03/11/2004 | DE10238865A1 New carboxamides are melanin-concentrating hormone receptor antagonists, useful for treating e.g. metabolic diseases, diabetes, eating disorders, cardiovascular disease, emotional disorders, reproductive and memory disorders |
| 03/10/2004 | EP1395571A1 Compounds and methods for the treatment or prevention of flavivirus infections |
| 03/10/2004 | EP1395558A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |